Ark Therapeutics Group plc – 20 February 2015

Wednesday 4th March, 2015

Marriott Harrison LLP advises Ark Therapeutics Group plc on its Main Market admission.  Corporate partner Simon Charles acted for Ark Therapeutics Group plc on its acquisition of veterinary care provider Premier Veterinary Group Limited, and a refinancing of Ark including the issue of new ordinary shares and a secured group refinancing facility.  The enlarged group was admitted to the Main Market of London Stock Exchange Plc on Friday 27 February 2015 following the issue of a UKLA – approved prospectus on Thursday 26 February 2015.  Other team members involved were Gavin Adams and Fran Spooner (Corporate), Mark Lavers and Abbey Wiggett (Property) and Bob Cordran.

Simon Charles
MH Corporate